News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
23,448 Results
Type
Article (1054)
Company Profile (1)
Press Release (22393)
Section
Business (11984)
Career Advice (19)
Deals (1627)
Drug Delivery (6)
Drug Development (2035)
FDA (293)
Job Trends (495)
News (15085)
Policy (580)
Tag
Academia (26)
Adcomms (1)
Allergies (2)
Alliances (748)
ALS (2)
Alzheimer's disease (32)
Antibody-drug conjugate (ADC) (2)
Approvals (301)
Artificial intelligence (3)
Bankruptcy (13)
Best Places to Work (391)
Biotechnology (1)
Bladder cancer (3)
Brain cancer (1)
Breast cancer (6)
Cancer (88)
Cardiovascular disease (4)
Career advice (18)
CAR-T (2)
Cell therapy (7)
Clinical research (1838)
Collaboration (12)
Compensation (11)
COVID-19 (29)
CRISPR (1)
C-suite (3)
Cystic fibrosis (1)
Data (125)
Depression (1)
Diabetes (13)
Diagnostics (200)
Digital health (2)
Drug discovery (2)
Drug pricing (8)
Duchenne muscular dystrophy (1)
Earnings (11180)
Editorial (1)
Events (2617)
Executive appointments (1)
FDA (446)
Funding (18)
Gene editing (2)
Gene therapy (7)
GLP-1 (29)
Government (42)
Grass and pollen (1)
Guidances (117)
Healthcare (562)
HIV (2)
IgA nephropathy (1)
Immunology and inflammation (5)
Immuno-oncology (1)
Indications (1)
Infectious disease (34)
Inflammatory bowel disease (2)
Influenza (5)
Intellectual property (3)
Interviews (3)
IPO (1256)
IRA (2)
Job creations (118)
Job search strategy (17)
Labor market (4)
Layoffs (8)
Leadership (1)
Legal (129)
Lung cancer (36)
Lymphoma (15)
Manufacturing (9)
MASH (5)
Medical device (525)
Medtech (527)
Mergers & acquisitions (377)
Metabolic disorders (32)
Multiple sclerosis (6)
NASH (1)
Neurodegenerative disease (1)
Neuropsychiatric disorders (2)
Neuroscience (56)
NextGen: Class of 2025 (169)
Non-profit (51)
Now hiring (2)
Obesity (18)
Opinion (5)
Pain (5)
Pancreatic cancer (1)
Parkinson's disease (8)
Patents (4)
Patient recruitment (2)
Peanut (1)
People (746)
Phase I (471)
Phase II (706)
Phase III (770)
Pipeline (349)
Policy (6)
Postmarket research (70)
Preclinical (132)
Prostate cancer (3)
Radiopharmaceuticals (7)
Rare diseases (11)
Real estate (128)
Regulatory (455)
Reports (3)
Research institute (21)
Resumes & cover letters (2)
RNA editing (1)
Schizophrenia (5)
Series A (1)
Series B (2)
Spinal muscular atrophy (10)
Startups (77)
Tariffs (2)
The Weekly (1)
Vaccines (13)
Weight loss (12)
Women's health (3)
Date
Last 7 days (35)
Last 30 days (70)
Last 365 days (1249)
2025 (1013)
2024 (1339)
2023 (1587)
2022 (1871)
2021 (1899)
2020 (1616)
2019 (1274)
2018 (1033)
2017 (790)
2016 (383)
2015 (6962)
2014 (440)
2013 (248)
2012 (274)
2011 (333)
2010 (374)
Location
Africa (19)
Alabama (2)
Arizona (3)
Asia (1326)
Australia (186)
California (320)
Canada (106)
China (29)
Colorado (18)
Connecticut (17)
Delaware (17)
Europe (3273)
Florida (44)
Georgia (9)
Idaho (1)
Illinois (22)
India (2)
Indiana (23)
Japan (7)
Kansas (5)
Kentucky (3)
Louisiana (5)
Maine (4)
Maryland (51)
Massachusetts (250)
Michigan (10)
Minnesota (14)
Missouri (2)
Montana (1)
Nebraska (1)
Nevada (8)
New Hampshire (5)
New Jersey (139)
New York (109)
North Carolina (64)
Northern California (166)
Ohio (14)
Pennsylvania (99)
South America (38)
Southern California (120)
Tennessee (5)
Texas (44)
United States (1342)
Utah (20)
Virginia (5)
Washington D.C. (3)
Washington State (38)
Wisconsin (2)
23,448 Results for "155".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Marble Raises $15.5M Series A to Scale Access to Youth Mental Health Care
October 15, 2025
·
3 min read
Press Releases
Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155
October 29, 2025
·
7 min read
Press Releases
Boehringer and Click Therapeutics present pivotal data for investigational prescription digital therapeutic CT-155 showing a statistically significant reduction in negative symptoms of schizophrenia
October 14, 2025
·
13 min read
Press Releases
Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase 2 Study Protocol and Implements Cost Reduction Actions to Extend Cash Runway
September 23, 2025
·
8 min read
Press Releases
Seres Therapeutics to Present New Post Hoc Data From SER-155 Phase 1b Trial at IDWeek 2025, Highlighting Potential to Improve Outcomes in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant
October 15, 2025
·
6 min read
Press Releases
Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million
July 3, 2025
·
3 min read
Press Releases
Boehringer and Click Therapeutics’ investigational prescription digital therapeutic CT-155 meets primary endpoint in CONVOKE study for negative symptoms in schizophrenia
August 8, 2025
·
9 min read
Job Creations
Massachusetts Tax Incentives for Moderna, Vertex and More Creating 1,155 Jobs
Nineteen companies are receiving $21.4 million total in tax incentive awards to create 1,155 new life sciences jobs in Massachusetts. Moderna and Vertex received the largest awards and will add over 600 combined jobs.
October 24, 2024
·
4 min read
·
Angela Gabriel
Press Releases
Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting
May 28, 2025
·
7 min read
Funding
AIRNA Hits $155M Series B Haul To Advance RNA Editor for Rare Genetic Disease
AIRNA’s lead candidate AIR-001 works by correcting the most common pathologic mutation driving the rare disease alpha-1 antitrypsin deficiency.
April 1, 2025
·
2 min read
·
Tristan Manalac
1 of 2,345
Next
